We are live on ! Find out more
OM icon

Outset Medical

142 hedge funds and large institutions have $2.5B invested in Outset Medical in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more call options, than puts

Call options by funds: $4.11M | Put options by funds: $841K

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

76% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 34

10% more funds holding

Funds holding: 129142 (+13)

8% more capital invested

Capital invested by funds: $2.31B → $2.5B (+$196M)

0.59% more ownership

Funds ownership: 6.71%7.3% (+0.59%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
142
Holders Change
+13
Holders Change %
+10.08%
% of All Funds
2.49%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
26
Increased
60
Reduced
34
Closed
13
Calls
$4.11M
Puts
$841K
Net Calls
+$3.27M
Net Calls Change
+$3.27M
Name Holding Trade Value Shares
Change
Change in
Stake
Assenagon Asset Management
51
Assenagon Asset Management
Luxembourg
$2.85M -$958K -1,406 -27%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$2.8M -$288K -423 -10%
Tiger Global Management
53
Tiger Global Management
New York
$2.72M
Point72 Asset Management
54
Point72 Asset Management
Connecticut
$2.65M -$2.72M -3,994 -53%
CT
55
Columbia Trust
Oregon
$2.56M -$418K -613 -15%
PHP
56
Parkman Healthcare Partners
Connecticut
$2.49M -$908K -1,333 -28%
LP
57
LMR Partners
United Kingdom
$2.47M +$2.27M +3,333 New
HighTower Advisors
58
HighTower Advisors
Illinois
$2.39M +$163K +239 +8%
EP
59
Eversept Partners
New York
$2.35M -$2.72M -3,986 -56%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$2.29M +$89.9K +132 +4%
Marshall Wace
61
Marshall Wace
United Kingdom
$2.18M +$2.01M +2,943 New
BA
62
Bridgewater Associates
Connecticut
$2.18M -$149K -219 -7%
Prudential Financial
63
Prudential Financial
New Jersey
$2.11M +$643K +944 +50%
SEI Investments
64
SEI Investments
Pennsylvania
$1.88M -$273K -400 -14%
GAM
65
Griffin Asset Management
New York
$1.67M +$1.53M +2,252 New
UBS AM
66
UBS AM
Illinois
$1.66M +$363K +532 +31%
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$1.64M -$283K -415 -16%
Two Sigma Investments
68
Two Sigma Investments
New York
$1.59M +$1.46M +2,148 New
3F
69
360 Financial
Minnesota
$1.42M -$45.7K -67 -3%
Citigroup
70
Citigroup
New York
$1.26M +$1.03M +1,505 +768%
AIG
71
American International Group
New York
$1.24M -$27.3K -40 -2%
CS
72
Credit Suisse
Switzerland
$1.22M +$67.5K +99 +6%
CF
73
CNA Financial
Illinois
$1.13M +$367K +538 +55%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.12M -$100K -147 -9%
LBA
75
Letko, Brosseau & Associates
Quebec, Canada
$1.11M

OM Hedge Fund Activity: Q3 2021 in Review

142 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2021, worth a combined $2.5B — up 8.5% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new OM positions and 13 closed out — a net gain of 13 holders — while 60 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $45.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $100M.

  • 142 institutional investors held Outset Medical (OM) as of Q3 2021, up from 129 in Q2 2021.
  • Funds reported $2.5B of Outset Medical stock for Q3 2021, up 8.5% quarter-over-quarter.
  • 26 funds opened new Outset Medical positions in Q3 2021 and 13 closed out, a net change of +13 holders.
  • The largest Outset Medical buyer in Q3 2021 was BlackRock, an estimated $45.4M added.
  • The largest Outset Medical seller in Q3 2021 was T. Rowe Price Associates, an estimated $100M sold.

Based on aggregated 13F filings for Q3 2021.